SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder
8 references·11 citing·34 second hop
Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder (1999)Placebo-Controlled, Multicenter Study of …Obsessive Compulsive Disorder (2022)Obsessive Compulsive DisorderDouble-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder (1995)Double-blind Parallel Compari…A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder (1995)A 1 year double-blind placebo…Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. (1990)Results of a double-blind pla…The Yale-Brown Obsessive Compulsive Scale (1989)The Yale-Brown Obsessive Comp…The Yale-Brown Obsessive Compulsive Scale (1989)The Yale-Brown Obsessive Comp…Obsessive-Compulsive Disorder (1983)Obsessive-Compulsive DisorderDevelopment of a Rating Scale for Primary Depressive Illness (1967)Development of a Rating Scale…Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis (2017)Obsessive-compulsive disorder…Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders (2015)Reporting Bias in Clinical Tr…Obsessive–Compulsive Disorder (2014)Obsessive–Compulsive DisorderPredictors of treatment response to fluvoxamine in obsessive–compulsive disorder: An fMRI study (2009)Predictors of treatment respo…Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials (2009)Differences in Adverse Effect…World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)World Federation of Societies…Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment Study (2002)Sertraline and Fluoxetine Tre…Pharmacotherapy of anxious disorders (2002)Pharmacotherapy of anxious di…Sertraline in the Treatment of Restricting Anorexia Nervosa: An Open Controlled Trial (2001)Sertraline in the Treatment o…Management of anxiety disorders: The added challenge of comorbidity (2001)Management of anxiety disorde…Serotonergic drugs in the treatment of depressive and anxiety disorders (2000)Serotonergic drugs in the tre…Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Diagnostic and Statistical Manual of Mental Disorders (2013)Epidemiology of anxiety disorders in the 21st century (2015)Treatment of anxiety disorders (2017)Obsessive–compulsive disorder (2019)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)A RATING SCALE FOR DEPRESSION (1960)ECDEU Assessment Manual for Psychopharmacology (1976)Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity (1997)The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication (2008)Clomipramine Treatment of Obsessive-Compulsive Disorder (1980)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)Cerebral Glucose Metabolism in Childhood-Onset Obsessive-Compulsive Disorder (1989)Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases (1998)Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder (1999)Coefficient Alpha and the Internal Structure of Tests (1951)Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites (1984)The Obsessive-Complusive Inventory: Development and validation of a short version. (2002)Obsessive-Compulsive Disorder in Children and Adolescents (1989)Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder (2004)Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2008)Experimenter Effects in Behavioral Research (1968)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview (2011)Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: A review of current practice (2014)Tripping on nothing: placebo psychedelics and contextual factors (2020)A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults (2016)Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology (2005)Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology (2014)A New Depression Scale Designed to be Sensitive to Change (1979)Development and validation of a geriatric depression screening scale: A preliminary report (1982)The development of a Clinician-Administered PTSD Scale (1995)Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder (2008)
this work references cited by second hop

References

  • 1967Development of a Rating Scale for Primary Depressive Illness8,410 cited
  • 1989The Yale-Brown Obsessive Compulsive Scale7,814 cited
  • 1989The Yale-Brown Obsessive Compulsive Scale2,824 cited
  • 1983Obsessive-Compulsive Disorder347 cited
  • 2022Obsessive Compulsive Disorder306 cited
  • 1995Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder243 cited
  • 1990Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.136 cited
  • 1995A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder133 cited

Cited by

  • 2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision862 cited
  • 2009Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials204 cited
  • 2015Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders101 cited
  • 2014Obsessive–Compulsive Disorder79 cited
  • 2009Predictors of treatment response to fluvoxamine in obsessive–compulsive disorder: An fMRI study68 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2002Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment Study62 cited
  • 2000Serotonergic drugs in the treatment of depressive and anxiety disorders59 cited
  • 2001Management of anxiety disorders: The added challenge of comorbidity57 cited
  • 2001Sertraline in the Treatment of Restricting Anorexia Nervosa: An Open Controlled Trial55 cited
  • 2017Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis53 cited
  • 2002Pharmacotherapy of anxious disorders34 cited